-
- Patient “Now Approved” Page
-
- Patient “Now Approved” Page (Mobile)
-
- HCP “Now Approved” Page
-
- HCP “Now Approved” Page (Mobile)
Lorbrena Now Approved Sites
Brand: Lorbrena (lorlatinib), Tablets
Parent Company: Pfizer
Drug Type: Prescription
Drug Category: Oncology
Campaign: now-approved
Targeting: HCPs, Patients, Caregivers
Patient Website: https://www.lorbrena.com/
HCP Website: https://www.lorbrenahcp.com/